Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

NACOGDOCHES, Texas (KTRE) - Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular degeneration. “It refers to the back of ...

This advocacy week serves as a rallying call to policymakers and the public, shedding light on the challenges faced by individuals with vision loss due to macular degeneration. "Age-related macular ...

Romford woman Maria Johnston, 53, set up an online tributes page after her dad, Sidney Hartman, died in October 2024. The page has received £1,851.86 in donations, which has been given to the Macular ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Macular degeneration, also known as age-related macular degeneration or AMD, is an incurable eye disease that damages the middle part of the retina that's known as the macula, "which is ...